SSEAR 最新10-Q变化
将 SSEAR 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-14 与上一份 10-Q · 2026-05-14
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +10 | −5 | ~13 | 21 |
| 市场风险(第3项) | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~2 | 2 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):法律诉讼、风险因素、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-14
For the three months ended June 30, 2026, we had net income of $109,502, which consisted of interest earned on cash held in the Trust Account of $487,635, partially offset by formation and operating costs of $378,133.
On September 29, 2025, the Company entered into a letter of intent (the “Letter of Intent”) with Forever Young International Limited., a Cayman Islands exempted company and a health industry operator providing comprehensive management and support service solutions for medical institutions in China (…
The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of a Business Combination. In connection with the Company’s assessment of going concern considerat…
As of June 30, 2026, we had $6,081 in cash and cash equivalents held outside of the Trust Account and working capital deficit of $158,336. For the three months ended June 30, 2026, we had a net income of $109,502, which consists of interest earned on cash held in the Trust Account of $487,635, offse…
We had a negative cash flow of $106,053 in operating activities for the six months ended June 30, 2026. Subsequent to the consummation of the IPO, our liquidity requirements have been satisfied through the net proceeds from the IPO, the Private Placement, and loans from our Sponsor pursuant to the P…
相对上期删除的文字 · 来源:10-Q · 2026-05-14
The operating costs incurred in the period from January 18, 2024 (inception) to March 31, 2026 consist primarily of approximately $ 708,857 of professional fees, insurance, costs and fees associated with our financial reporting, listing and other public company costs. We expect to incur increased ex…
For the three months ended March 31, 2025, we had a net loss of $85,504, which consisted of formation and operating costs of $85,504.
On September 29, 2025, the Company entered into a letter of intent (the “Letter of Intent”) with Forever Young International Limited., a Cayman Islands exempted company and a health industry operator providing comprehensive management and support service solutions for medical institutions in China (…
As of March 31, 2026, the Company had $58,049 in cash and cash equivalents held outside of the Trust Account and working capital of $219,797. For the three months ended March 31, 2026, we had a net income of $325,230, which consists of interest earned on cash held in the Trust Account of $484,499, p…
We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of March 31, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议